Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents
The search for new metal-containing antitumor agents is still carried out at present. Although platinum compounds are used in clinical practice, they show drawbacks such as high general toxicity and primary or acquired resistance. Ruthenium compounds showed the best potential among non-platinum anti...
Gespeichert in:
| Veröffentlicht in: | Russian journal of inorganic chemistry 2021-04, Vol.66 (4), p.502-509 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 509 |
|---|---|
| container_issue | 4 |
| container_start_page | 502 |
| container_title | Russian journal of inorganic chemistry |
| container_volume | 66 |
| creator | Shutkov, I. A. Antonets, A. A. Tyurin, V. Yu Milaeva, E. R. Nazarov, A. A. |
| description | The search for new metal-containing antitumor agents is still carried out at present. Although platinum compounds are used in clinical practice, they show drawbacks such as high general toxicity and primary or acquired resistance. Ruthenium compounds showed the best potential among non-platinum antitumor agents, two of which—NAMI-A and KP1019 (КР1339)—are under clinical trials. In this work, we present the synthesis of full analogs of leader compound NAMI-A containing fragments of biologically active organic molecules, namely Lonidamine and Bexarotene. Electrochemical behavior of Ru(III) complexes has been studied and ease of reduction has been shown, which indicates the promise of their use as antitumor agents whose mechanism of action seems to be based on activation by metal atom reduction. The cytotoxicity of obtained complexes has been studied in vitro and IC
50
values have been determined. Two compounds have been selected for further study. |
| doi_str_mv | 10.1134/S0036023621030177 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2519029684</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2519029684</sourcerecordid><originalsourceid>FETCH-LOGICAL-c316t-5bfea30a9dddd7c3a2bd7d60b74b3e3e3e37ff0253c842aeed538115b688b4233</originalsourceid><addsrcrecordid>eNp1UEtLw0AQXkTBWv0B3ha86CG6j7x6TIuPQFTQeg6bZNJuaXbj7kbbf29iBA_izGEYvscMH0LnlFxTyv2bV0J4SBgPGSWc0Cg6QBMacOrFIeWHaDLA3oAfoxNrN4T4PoniCbIvnVuDkl1zmabpFV7opt3CDizWNX5KHlMvwct9C_hTujXO5EqoyuK5sFBhrXCmlaxEIxXgHsBz2AmjHQyrxYlysjV6K2swwskPwMkKlLOn6KgWWwtnP3OK3u5ul4sHL3u-TxdJ5pWchs4LihoEJ2JW9RWVXLCiiqqQFJFfcPjuqK4JC3gZ-0wAVAGPKQ2KMI4Ln3E-RRejb__EewfW5RvdGdWfzFlAZ4TNwtjvWXRklUZba6DOWyMbYfY5JfmQbf4n217DRo3tuWoF5tf5f9EX_hx6zQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2519029684</pqid></control><display><type>article</type><title>Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents</title><source>SpringerLink Journals - AutoHoldings</source><creator>Shutkov, I. A. ; Antonets, A. A. ; Tyurin, V. Yu ; Milaeva, E. R. ; Nazarov, A. A.</creator><creatorcontrib>Shutkov, I. A. ; Antonets, A. A. ; Tyurin, V. Yu ; Milaeva, E. R. ; Nazarov, A. A.</creatorcontrib><description>The search for new metal-containing antitumor agents is still carried out at present. Although platinum compounds are used in clinical practice, they show drawbacks such as high general toxicity and primary or acquired resistance. Ruthenium compounds showed the best potential among non-platinum antitumor agents, two of which—NAMI-A and KP1019 (КР1339)—are under clinical trials. In this work, we present the synthesis of full analogs of leader compound NAMI-A containing fragments of biologically active organic molecules, namely Lonidamine and Bexarotene. Electrochemical behavior of Ru(III) complexes has been studied and ease of reduction has been shown, which indicates the promise of their use as antitumor agents whose mechanism of action seems to be based on activation by metal atom reduction. The cytotoxicity of obtained complexes has been studied in vitro and IC
50
values have been determined. Two compounds have been selected for further study.</description><identifier>ISSN: 0036-0236</identifier><identifier>EISSN: 1531-8613</identifier><identifier>DOI: 10.1134/S0036023621030177</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Anticancer properties ; Antiproliferatives ; Chemistry ; Chemistry and Materials Science ; Electrochemical analysis ; Inorganic Chemistry ; Organic chemistry ; Platinum compounds ; Reduction (metal working) ; Ruthenium compounds ; Synthesis and Properties of Inorganic Compounds ; Toxicity</subject><ispartof>Russian journal of inorganic chemistry, 2021-04, Vol.66 (4), p.502-509</ispartof><rights>Pleiades Publishing, Ltd. 2021. ISSN 0036-0236, Russian Journal of Inorganic Chemistry, 2021, Vol. 66, No. 4, pp. 502–509. © Pleiades Publishing, Ltd., 2021. Russian Text © The Author(s), 2021, published in Zhurnal Neorganicheskoi Khimii, 2021, Vol. 66, No. 4, pp. 477–484.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c316t-5bfea30a9dddd7c3a2bd7d60b74b3e3e3e37ff0253c842aeed538115b688b4233</citedby><cites>FETCH-LOGICAL-c316t-5bfea30a9dddd7c3a2bd7d60b74b3e3e3e37ff0253c842aeed538115b688b4233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S0036023621030177$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S0036023621030177$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Shutkov, I. A.</creatorcontrib><creatorcontrib>Antonets, A. A.</creatorcontrib><creatorcontrib>Tyurin, V. Yu</creatorcontrib><creatorcontrib>Milaeva, E. R.</creatorcontrib><creatorcontrib>Nazarov, A. A.</creatorcontrib><title>Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents</title><title>Russian journal of inorganic chemistry</title><addtitle>Russ. J. Inorg. Chem</addtitle><description>The search for new metal-containing antitumor agents is still carried out at present. Although platinum compounds are used in clinical practice, they show drawbacks such as high general toxicity and primary or acquired resistance. Ruthenium compounds showed the best potential among non-platinum antitumor agents, two of which—NAMI-A and KP1019 (КР1339)—are under clinical trials. In this work, we present the synthesis of full analogs of leader compound NAMI-A containing fragments of biologically active organic molecules, namely Lonidamine and Bexarotene. Electrochemical behavior of Ru(III) complexes has been studied and ease of reduction has been shown, which indicates the promise of their use as antitumor agents whose mechanism of action seems to be based on activation by metal atom reduction. The cytotoxicity of obtained complexes has been studied in vitro and IC
50
values have been determined. Two compounds have been selected for further study.</description><subject>Anticancer properties</subject><subject>Antiproliferatives</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Electrochemical analysis</subject><subject>Inorganic Chemistry</subject><subject>Organic chemistry</subject><subject>Platinum compounds</subject><subject>Reduction (metal working)</subject><subject>Ruthenium compounds</subject><subject>Synthesis and Properties of Inorganic Compounds</subject><subject>Toxicity</subject><issn>0036-0236</issn><issn>1531-8613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1UEtLw0AQXkTBWv0B3ha86CG6j7x6TIuPQFTQeg6bZNJuaXbj7kbbf29iBA_izGEYvscMH0LnlFxTyv2bV0J4SBgPGSWc0Cg6QBMacOrFIeWHaDLA3oAfoxNrN4T4PoniCbIvnVuDkl1zmabpFV7opt3CDizWNX5KHlMvwct9C_hTujXO5EqoyuK5sFBhrXCmlaxEIxXgHsBz2AmjHQyrxYlysjV6K2swwskPwMkKlLOn6KgWWwtnP3OK3u5ul4sHL3u-TxdJ5pWchs4LihoEJ2JW9RWVXLCiiqqQFJFfcPjuqK4JC3gZ-0wAVAGPKQ2KMI4Ln3E-RRejb__EewfW5RvdGdWfzFlAZ4TNwtjvWXRklUZba6DOWyMbYfY5JfmQbf4n217DRo3tuWoF5tf5f9EX_hx6zQ</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Shutkov, I. A.</creator><creator>Antonets, A. A.</creator><creator>Tyurin, V. Yu</creator><creator>Milaeva, E. R.</creator><creator>Nazarov, A. A.</creator><general>Pleiades Publishing</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210401</creationdate><title>Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents</title><author>Shutkov, I. A. ; Antonets, A. A. ; Tyurin, V. Yu ; Milaeva, E. R. ; Nazarov, A. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c316t-5bfea30a9dddd7c3a2bd7d60b74b3e3e3e37ff0253c842aeed538115b688b4233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anticancer properties</topic><topic>Antiproliferatives</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Electrochemical analysis</topic><topic>Inorganic Chemistry</topic><topic>Organic chemistry</topic><topic>Platinum compounds</topic><topic>Reduction (metal working)</topic><topic>Ruthenium compounds</topic><topic>Synthesis and Properties of Inorganic Compounds</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shutkov, I. A.</creatorcontrib><creatorcontrib>Antonets, A. A.</creatorcontrib><creatorcontrib>Tyurin, V. Yu</creatorcontrib><creatorcontrib>Milaeva, E. R.</creatorcontrib><creatorcontrib>Nazarov, A. A.</creatorcontrib><collection>CrossRef</collection><jtitle>Russian journal of inorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shutkov, I. A.</au><au>Antonets, A. A.</au><au>Tyurin, V. Yu</au><au>Milaeva, E. R.</au><au>Nazarov, A. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents</atitle><jtitle>Russian journal of inorganic chemistry</jtitle><stitle>Russ. J. Inorg. Chem</stitle><date>2021-04-01</date><risdate>2021</risdate><volume>66</volume><issue>4</issue><spage>502</spage><epage>509</epage><pages>502-509</pages><issn>0036-0236</issn><eissn>1531-8613</eissn><abstract>The search for new metal-containing antitumor agents is still carried out at present. Although platinum compounds are used in clinical practice, they show drawbacks such as high general toxicity and primary or acquired resistance. Ruthenium compounds showed the best potential among non-platinum antitumor agents, two of which—NAMI-A and KP1019 (КР1339)—are under clinical trials. In this work, we present the synthesis of full analogs of leader compound NAMI-A containing fragments of biologically active organic molecules, namely Lonidamine and Bexarotene. Electrochemical behavior of Ru(III) complexes has been studied and ease of reduction has been shown, which indicates the promise of their use as antitumor agents whose mechanism of action seems to be based on activation by metal atom reduction. The cytotoxicity of obtained complexes has been studied in vitro and IC
50
values have been determined. Two compounds have been selected for further study.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><doi>10.1134/S0036023621030177</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0036-0236 |
| ispartof | Russian journal of inorganic chemistry, 2021-04, Vol.66 (4), p.502-509 |
| issn | 0036-0236 1531-8613 |
| language | eng |
| recordid | cdi_proquest_journals_2519029684 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Anticancer properties Antiproliferatives Chemistry Chemistry and Materials Science Electrochemical analysis Inorganic Chemistry Organic chemistry Platinum compounds Reduction (metal working) Ruthenium compounds Synthesis and Properties of Inorganic Compounds Toxicity |
| title | Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T05%3A41%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ruthenium(III)%20Complexes%20of%20NAMI-A%20Type%20with%20Ligands%20Based%20on%20Lonidamine%20and%20Bexarotene%20as%20Antiproliferative%20Agents&rft.jtitle=Russian%20journal%20of%20inorganic%20chemistry&rft.au=Shutkov,%20I.%20A.&rft.date=2021-04-01&rft.volume=66&rft.issue=4&rft.spage=502&rft.epage=509&rft.pages=502-509&rft.issn=0036-0236&rft.eissn=1531-8613&rft_id=info:doi/10.1134/S0036023621030177&rft_dat=%3Cproquest_cross%3E2519029684%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2519029684&rft_id=info:pmid/&rfr_iscdi=true |